Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03525444
Brief Title: A Phase 3 Study of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)

First Submitted : May 2, 2018
First Submitted that Met QC Criteria : May 2, 2018
First Posted : May 15, 2018

Last Update Submitted that Met QC Criteria : December 3, 2018
Last Update Posted : December 4, 2018